What Are The 10 Most Common Qualifying Conditions For CBD Oil?
So far, 29 states, plus Puerto Rico and Washington D.C. have passed laws permitting doctors to recommend CBD oil to their patients. What this means is that the lawmaking bodies in these states have listened to the testimony and looked at the evidence and decided that CBD has some possible medical value.
Each state allowing doctors to recommend CBD oil has its own list of qualifying conditions. While some states include broad categories of qualifying conditions, others strictly limit doctors to a short list of, particularly severe conditions.
Here are the most common state-approved qualifying conditions for CBD oil prescriptions:
Epilepsy and Seizures
Epilepsy is a neurological condition characterized by sudden episodes of uncontrolled electrical activity in the brain which can result in seizures or loss of consciousness. CBD has been shown in Phase I clinical trials to reduce seizures in children with Dravet Syndrome, an intractable form of childhood epilepsy.
In some states, CBD oil may be recommended by doctors to combat the side effects of chemotherapy making cancer one of the most common qualifying conditions. However, while much more research is needed in this area, some researchers believe that CBD oil has the potential to treat cancer itself.
Chronic Pain and Neuropathy
Another common state-approved qualifying condition for CBD oil is chronic pain. Neuropathic pain which stems from damage to the nervous system is typical of many severe health conditions such as diabetes and multiple sclerosis. Research has shown that CBD oil may reduce the perception of pain and the inflammation that causes it.
Multiple sclerosis is a debilitating disease in which the protective covering of nerves is destroyed by the immune system. Some research suggests that CBD may not only provide an effective treatment for managing symptoms associated with the disease but may also help to slow the disease’s progression.
Crohn’s Disease and Colitis
Crohn’s disease and colitis are common qualifying conditions for CBD oil prescriptions. These autoimmune diseases cause chronic inflammation in the gastrointestinal tract. Some researchers believe that these diseases may be connected to a deficiency of cannabinoids.
Lou Gehrig’s Disease/ALS
Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis or ALS, is a rare neurological disorder. Some research suggests that CBD oil could help slow the progression of ALS. CBD’s anti-inflammatory, antioxidant and neuroprotective effects may be responsible for its therapeutic potential in treating ALS.
Arthritis is a condition thought to be caused by abnormal functioning of the immune system that causes stiff, achy, inflamed, painful joints. CBD oil’s anti-inflammatory and pain-relieving properties may provide relief for many suffering with this chronic condition.
Alzheimer’s Disease and Dementia
Research into CBD’s potential as a treatment for Alzheimer’s Disease suggests that it may be effective in slowing the progression of this neurodegenerative disorder. CBD could help to manage some of the behavioral symptoms of dementia, including agitation and aggression. But there is also evidence that CBD may target the underlying processes behind Alzheimer's Disease.
Post-Traumatic Stress Disorder (PTSD)
PTSD is a psychiatric disorder that develops in the aftermath of extremely disturbing or life-threatening experiences such as combat exposure, rape, childhood physical abuse, sexual molestation, physical attack, and other violence. There is preclinical evidence that does suggest CBD may be an effective treatment for anxiety disorders including PTSD.
Parkinson’s affects an estimated one million Americans. It is the second most common neurological disorder after Alzheimer’s Disease. Patients with the disease suffer symptoms of insomnia, anxiety, motor coordination impairment, and irritability. Clinical trials have shown that CBD oil can potentially improve anxiety, psychosis, cognition, sleep, fatigue, and emotional stability in those with Parkinson’s.